sales, strongest profit ever in 2025 Hanmi raises oncology stakes with phase 2 belvarafenib combo in NRAS-mutant melanoma Hanmi amends Aptose merger deal, pushes shareholder vote to March and adds $11.1 mil
Is it for own production, resale or research purposes
Bringing the blood tests, the fibrosis staging, the risk stratification and the ongoing management into one accessible pathway, instead of scattered across a system that makes people wait 18 months or pay a fortune
Used in Japan-quality formulations
Beyond engineering live probiotics, their derivativessuch as exosomes and membrane vesiclesprovide platforms for delivering nucleic acid therapeutics and nanozymes
Glutathione has been shown to have potential benefits in treating fatty liver disease by reducing oxidative stress and inflammation in the liver